Skip to Content
Morningstar

ARK Genomic Revolution ETF ARKG

Morningstar Medalist Rating
Medalist Rating as of | See ARK Investment Hub

Morningstar’s Analysis ARKG

Will ARKG outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable ARKG’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the ARKG management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of ARKG’s parent organization’s priorities and whether they’re in line with investors’ interests.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit ARK Genomic Revolution ETF to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ARKG

More ARKG Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 54.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Twist Bioscience Corp

9.91 121.8 Mil
Healthcare

CRISPR Therapeutics AG

7.54 92.7 Mil
Healthcare

CareDx Inc

6.71 82.4 Mil
Healthcare

Recursion Pharmaceuticals Inc Class A

5.62 69.1 Mil
Healthcare

Ionis Pharmaceuticals Inc

4.90 60.2 Mil
Healthcare

Intellia Therapeutics Inc

4.73 58.1 Mil
Healthcare

Schrodinger Inc Ordinary Shares

3.89 47.8 Mil
Healthcare

Beam Therapeutics Inc

3.88 47.6 Mil
Healthcare

Nurix Therapeutics Inc Ordinary Shares

3.56 43.8 Mil
Healthcare

Arcturus Therapeutics Holdings Inc

3.40 41.8 Mil
Healthcare